News
Media coverage of HCCI’s original research

For general media inquiries or to propose collaborative projects, please contact us

Dec
19

HCCImpact 2024

High and rising health care costs affect individuals, families, and businesses across the country, and they have for decades. Cost forces difficult choices between health care and other needs. The Health Care Cost Institute's mission of using data and analytics to improve the US health care system recognizes that people are at the heart of health care, and we are committed to putting our clai...

Continue reading
Dec
16

Commercial Prices for Ground Ambulance are Double Medicare Rates

Ambulances contribute to urgent lifesaving and life-enhancing medical care, but the unplanned nature of this essential service can lead to high unexpected costs to patients. This HCCI data brief focuses on ground ambulances, which make up 98% of all ambulance trips, and builds upon earlier work that explored 10-year trends in ambulance prices, utilization, spending, and the frequency of out-of-net...

Continue reading
Dec
03

Commercial inpatient hospital price growth driven by system affiliation and nonprofit-status hospitals

Recent data from the Health Care Cost Institute (HCCI) show that growth in hospitals' commercial inpatient prices was higher in system-affiliated and non-profit hospitals from 2012-2021.  Key Findings: In the backdrop of a wave of hospital mergers, system-affiliated non-profit hospitals account for more than half of short-term general acute care hospitals in the US (from 50.6% in 2012 to 62.5...

Continue reading
Nov
04

Five years since US first biosimilar market entry, first signs of savings attributed to biosimilars in the employer-sponsored insurance population

Biologic drugs treat a range of diseases such as cancer, diabetes, retinal diseases, Crohn's disease and many other conditions. Despite accounting for use by just 2% of Americans, spending on biologics is a major driver of drug spending in the United States. Biologics often come with a hefty price tag; for example, the most commonly used biologic drug, Humira, can have out-of-pocket costs that run...

Continue reading
Oct
31

Price Markups for Clinical Labs: Employer-based Insurance Pays Hospital Outpatient Departments 3x Than Physician Offices and Independent Labs for Identical Tests

The Health Care Cost Institute (HCCI) in collaboration with West Health conducted an analysis of the high prices that employer-based insurance pays hospital outpatient departments for clinical lab tests. We found that insurers are paying, on average, 3 times more for common lab tests such as blood and urine test when billed by hospital outpatient departments compared to independent laboratories. D...

Continue reading